Maynard Um
-
-
-
-
-
-
-
Maxim Group Starts Imunon (IMNN) at Buy
-
-
-
-
-
-
-
IMUNON receives Nasdaq extension to complete compliance plan
-
-
-
-
-
-
-
Imunon (IMNN) Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy
-
-
-
-
-
-
-
Imunon (IMNN) Announces $10 Million Registered Direct Offering
-
448,359 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

